When was Regencell Bioscience Holdings Limited stock made available for the first time to the public?

The IPO Date for Regencell Bioscience Holdings Limited is 2021-07-16. On this 2021-07-16, Regencell Bioscience Holdings Limited stock was made publicly available.

Where is the headquarters of Regencell Bioscience Holdings Limited stock?

Headquarters information for Regencell Bioscience Holdings Limited is currently unavailable. We'll update this as soon as it's available.

What industry does Regencell Bioscience Holdings Limited belong to?

The Regencell Bioscience Holdings Limited belongs to Drug Manufacturers - Specialty & Generic.

Regencell Bioscience Holdings Limited

RGC•NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

$17.40

$-2.79(-13.82%)

Regencell Bioscience Holdings Limited (RGC) Company Profile & Overview

Explore Regencell Bioscience Holdings Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Regencell Bioscience Holdings Limited (RGC) Company Profile & Overview

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

CEOMr. Yat-Gai Au

Contact Information

https://www.regencellbioscience.com

852 2155 0823

First Commercial Building, Causeway Bay, KY1-1107

Company Facts

12 Employees

IPO DateJul 16, 2021

CountryHK

Actively Trading

Frequently Asked Questions

;